• QUYNH THI HUONG BUI Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
  • KHOI XUAN PHAM Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
  • TIEN HOANG TRAN Department of Pharmacy, University Medical Center, Ho Chi Minh City, Vietnam.
  • LAN THI TUYET LE Department of Screening Respiratory Function, University Medical Center, Ho Chi Minh City, Vietnam.
  • HO NHU NGUYEN Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.


Objectives: Asthma is a chronic disease resulting in reduced quality of life (QoL) of most affected individuals. Training in asthma-related knowledge, inhaler skills, medicine usage, and the prevention of adverse drug events is demonstrated to improve asthma patients’ QoL. Therefore, the research was conducted to evaluate the effectiveness of education intervention undertaken by pharmacists on QoL of patients with asthma.

Methods: We conducted a clinical randomized controlled trial among asthmatic outpatients aged 18 years or older in the Department of Screening Respiratory Function, University Medical Center, Ho Chi Minh City, Vietnam. Patients were randomized into an intervention group (IG) and a non-IG (NIG). The clinical pharmacists’ intervention program included training in asthma-related knowledge, inhaler technique, recognition, prevention of adverse drug events, and lifestyle adjustment. Participant screening was conducted using the telephone on a monthly basis. QoL was measured using the Vietnamese Version of the Mini Asthma QoL Questionnaire (MiniAQLQ). The main outcome was the difference in QoL scores between IG and NIG after 3 months follow-up.

Results: After 3 months, the number of patients with asthma in the IG and in the NIG was 173 and 96, respectively. QoL mean scores in the IG patients were significantly higher than those in their NIG counterparts (1.79±1.01 vs. 1.06±0.93, respectively, p<0.001). Pharmacist-based interventions overall QoL scores (multivariate-adjusted regression coefficient =0.362; p<0.001).

Conclusions: Clinical pharmacist-led counseling can improve asthmatic patients’ QoL.

Keywords: Quality of life,, Clinical pharmacist-led intervention,, Mini Asthma Quality of life Questionnaire,, Randomized controlled trial,, Asthmatic education.


1. GBD Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: A systematic analysis for the global burden of disease study 2015. Lancet Respir Med 2017;5:691-706.
2. Song WJ, Kang MG, Chang YS, Cho SH. Epidemiology of adult asthma in Asia: Toward a better understanding. Asia Pac Allergy 2014;4:75-85.
3. Loftus PA, Wise SK. Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg 2016;24:245-9.
4. Sembajwe G, Cifuentes M, Tak SW, Kriebel D, Gore R, Punnett L, et al. National income, self-reported wheezing and asthma diagnosis from the world health survey. Eur Respir J 2010;35:279-86.
5. Wijesinghe M, Weatherall M, Perrin K, Crane J, Beasley R. International trends in asthma mortality rates in the 5-to 34-year age group: A call for closer surveillance. Chest 2009;135:1045-9.
6. Tabeshour J, Zirak MR, Mirakhorli H, Bazzaz BS, Afzalaghaee M, Kerachian M, et al. Community pharmacist attitude toward collaboration with physicians. Int J Pharm Pharm Sci 2017;9:212-7.
7. Cheema E, Sutcliffe P, Singer DR. Community pharmacist-led new medicine service for patients with a long term medical condition: A cross-sectional study. Int J Pharm Pharm Sci 2017;9:129-33.
8. Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Lilimos F. Pharmacists interventions on clinical asthma outcomes: A systematic review. Eur Respir J2016;47:1134-43.
9. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008;31:790-9.
10. Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: A systematic review. Int J Clin Pharm 2014;36:882-91.
11. Robert C Weisell. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr 2002;11:S681-4.
12. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention. Strategy Report; 2016.
13. Tran HT, Pham XK, Bui TH. Reliability of Vietnamese version of mini AQLQ (mini asthma quality of life questionaire). Ho Chi Minh City Med J 2018;22:119.
14. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J 1999;14:32-8.
15. Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P, et al. Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharm World Sci 2008;30:869-75.
16. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy asthma care program (PACP) improves outcomes for patients in the community. Thorax 2007;62:496-502.
17. Plaza V, Peiró M, Torrejón M, Fletcher M, López-Viña A, Ignacio JM, et al. A repeated short educational intervention improves asthma control and quality of life. Eur Respir J 2015;46:1298-307.
18. Shanmugam S, Varughese J, Nair MA, Balasubramanian R, Velu S, Bhojan C, et al. Pharmaceutical care for asthma patients: A Developing country’s experience. J Res Pharm Pract 2012;1:66-71.
19. Wang KY, Chian CF, Lai HR, Tarn YH, Wu CP. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients. Pharm World Sci 2010;32:721-9.
20. Petkova VB. Pharmaceutical care for asthma patients: A community pharmacy-based pilot project. Allergy Asthma Proc 2008;29:55-61.
21. Brown R. Behavioral issues in asthma management. Allergy Asthma Proc 2001;22:67-9.
22. Onda M, Sakurai H, Hayase Y, Sakamaki H, Arakawa Y, Yasukawa F, et al. Effects of patient-pharmacist communication in the treatment of asthma. Yakugaku Zasshi 2009;129:427-33.
23. Klijn SL, Hiligsmann M, Evers SM, Roman-Rodriguez M, van der Molen T, Van Boven JF. Effectiveness and success factors of educational inhalertechnique interventions in asthma and COPD patients: Asystematic review. Eur Respir J 2016;48:OA1998.
24. Foot H, La Caze A, Baker P, Cottrell N. Better understanding the influence and complexity of beliefs on medication adherence in asthma. Patient Educ Couns 2019;102:564-70.
25. Axtell S, Haines S, Fairclough J. Effectiveness of various methods of teaching proper inhaler technique. J Pharm Pract 2017;30:195-201.
26. Holtz B, Whitten P. Managing asthma with mobile phones: A feasibility study. Telemed J E Health 2009;15:907-9.
27. Lv Y, Zhao H, Liang Z, Dong H, Liu L, Zhang D, et al. A mobile phone short message service improves perceived control of asthma: A randomized controlled trial. Telemed J E Health 2012;18:420-6.
28. Pinnock H, Slack R, Pagliari C, Price D, Sheikh A. Understanding the potential role of mobile phone-based monitoring on asthma self-management: Qualitative study. Clin Exp Allergy 2007;37:794-802.
29. Nelson P, Young HN, Knobloch MJ, Griesbach SA. Telephonic monitoring and optimization of inhaler technique. Telemed J E Health 2011;17:734-40.
30. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009;43:85-97.
31. Saini B, Krass I, Smith L, Bosnic-Anticevich S, Armour C. Role of community pharmacists in asthma Australian research highlighting pathways for future primary care models. Australas Med J 2011;4:190-200.
32. Trinh HT, Nguyen HT, Pham VT, Ba HL, Dong PT, Cao TT, et al. Hospital clinical pharmacy services in Vietnam. Int J Clin Pharm 2018;40:1144-53.
341 Views | 156 Downloads
How to Cite
QUYNH THI HUONG BUI, KHOI XUAN PHAM, TIEN HOANG TRAN, LAN THI TUYET LE, and HO NHU NGUYEN. “A IMPACT OF A PHARMACIST-LED EDUCATIONAL INTERVENTION ON QUALITY OF LIFE AMONG PATIENTS WITH ASTHMA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 6, May 2019, pp. 307-12, doi:10.22159/ajpcr.2019.v12i6.33705.
Original Article(s)